<p class="MsoNormal">In a statement, the firm added that "between 85 and 100 million doses will be distributed in the US, while the rest of the world will receive the remaining 15 to 25 million doses." T<span style="background-color:#ffffff">he company says it is on track to manufacture between 500 million to 1 billion doses globally in 2021.</span></p><p class="MsoNormal"></p>
